215 related articles for article (PubMed ID: 34387827)
1. Qishen Taohong Granule () as Adjuvant Therapy for Improving Cardiac Function and Quality of Life in Patients with Chronic Heart Failure: A Randomized Controlled Trial.
Li XX; Wu Y; Fan ZJ; Cui J; Li D; Lin Q; Zhuang R; Yan RK; Lin Q; Li Y
Chin J Integr Med; 2022 Jan; 28(1):12-19. PubMed ID: 34387827
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
Wang J; Shi J; Wei J; Wang J; Gao K; Li X; Chen J; Li S; Zhao H; Wang W
Trials; 2017 Oct; 18(1):468. PubMed ID: 29017565
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.
Li X; Zhang J; Huang J; Ma A; Yang J; Li W; Wu Z; Yao C; Zhang Y; Yao W; Zhang B; Gao R;
J Am Coll Cardiol; 2013 Sep; 62(12):1065-1072. PubMed ID: 23747768
[TBL] [Abstract][Full Text] [Related]
4. Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial.
Wang X; Hu D; Dang S; Huang H; Huang CX; Yuan MJ; Tang YH; Zheng QS; Yin F; Zhang S; Zhang BL; Gao RL;
Chin Med J (Engl); 2017 Jul; 130(14):1639-1647. PubMed ID: 28685712
[TBL] [Abstract][Full Text] [Related]
5. Effects of multifaceted optimization management for chronic heart failure: a multicentre, randomized controlled study.
Pan G; Ji W; Wang X; Li S; Zheng C; Lyu W; Feng X; Xia Y; Xiong Z; Shan H; Yang H; Zou X
ESC Heart Fail; 2023 Feb; 10(1):133-147. PubMed ID: 36178015
[TBL] [Abstract][Full Text] [Related]
6. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
7. Baduanjin exercise for patients with ischemic heart failure on phase-II cardiac rehabilitation (BEAR trial): study protocol for a prospective randomized controlled trial.
Yu M; Li S; Li S; Li J; Xu H; Chen K
Trials; 2018 Jul; 19(1):381. PubMed ID: 30012193
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial.
Maulik SK; Wilson V; Seth S; Bhargava B; Dua P; Ramakrishnan S; Katiyar CK
Phytomedicine; 2016 Oct; 23(11):1211-9. PubMed ID: 26988798
[TBL] [Abstract][Full Text] [Related]
9. The effects of qishen granules for patients with chronic heart failure: A multicenter randomized double-blind placebo-controlled trial.
Du K; Liu J; Tan N; Huang X; Wang J; Zhao H; Wang W
Front Pharmacol; 2022; 13():1017734. PubMed ID: 36618925
[No Abstract] [Full Text] [Related]
10. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP;
JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of Criterion Validity of CHF-Quality of Life Scale of Integrative Medicine].
Wan J; Lin Q; Su JZ; Tan H; Li PH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Nov; 36(11):1300-1303. PubMed ID: 30641619
[TBL] [Abstract][Full Text] [Related]
12. Effects of trimetazidine in nonischemic heart failure: a randomized study.
Winter JL; Castro PF; Quintana JC; Altamirano R; Enriquez A; Verdejo HE; Jalil JE; Mellado R; Concepción R; Sepúlveda P; Rossel V; Sepúlveda L; Chiong M; García L; Lavandero S
J Card Fail; 2014 Mar; 20(3):149-54. PubMed ID: 24412523
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of biventricular pacing on preventing heart failure in patients with high degree atrioventricular block (BIVPACE-AVB Trial)].
Zhang XY; Shan QJ; Su YG; Yan J; Bao ZH; Gu X; Qiu JP; Qin SM; Xu J; Su H; Zhu H; Guo JF; Lu JP; Zou JG; Chen ML; Xu D; Cao KJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Apr; 44(4):331-7. PubMed ID: 27112612
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
15. A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome).
Guo L; Yuan H; Zhang D; Zhang J; Hua Q; Ma X; Chen K
Medicine (Baltimore); 2020 May; 99(21):e20271. PubMed ID: 32481305
[TBL] [Abstract][Full Text] [Related]
16. Effect of yangxinkang tablets on chronic heart failure: A multi-center randomized double-blind placebo-controlled trial.
Xian SX; Yang ZQ; Ren PH; Ye XH; Ye SL; Wang QH; Wang ZH; Shen SJ; Huang XW
Chin J Integr Med; 2015 Oct; 21(10):733-42. PubMed ID: 25948124
[TBL] [Abstract][Full Text] [Related]
17. [Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
Zhao XY; Yang YJ; Zhang J; Kang LM; Wei BQ; Gao XJ; Lü R; Zhang CL
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):486-90. PubMed ID: 19927626
[TBL] [Abstract][Full Text] [Related]
18. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
[TBL] [Abstract][Full Text] [Related]
19. Effect of allogeneic adipose tissue-derived mesenchymal stromal cell treatment in chronic ischaemic heart failure with reduced ejection fraction - the SCIENCE trial.
Qayyum AA; van Klarenbosch B; Frljak S; Cerar A; Poglajen G; Traxler-Weidenauer D; Nadrowski P; Paitazoglou C; Vrtovec B; Bergmann MW; Chamuleau SAJ; Wojakowski W; Gyöngyösi M; Kraaijeveld A; Hansen KS; Vrangbaek K; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Mathiasen AB; Ekblond A; Haack-Sørensen M; Kastrup J;
Eur J Heart Fail; 2023 Apr; 25(4):576-587. PubMed ID: 36644821
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP;
Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
